FDA finds increased blood clot, death risk associated with XeljanzJuly 26, 2019Rheumatoid ArthritisPsoriatic Arthritis
Hadlima approved as fourth adalimumab biosimilar in U.S.July 23, 2019Rheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisSpondyloarthropathiesPediatrics
Secukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trialJuly 16, 2019Psoriatic Arthritis
Flu vaccine succeeds in TNF inhibitor usersJuly 3, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Unacceptable pain despite inflammation control commonly occurs in PsA patientsJuly 2, 2019Psoriatic Arthritis
Systemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response ratesJune 27, 2019Psoriatic Arthritis
Obesity might be targetable driver of psoriatic arthritis progressionJune 26, 2019Psoriatic Arthritis
Carotid ultrasound may aid cardiovascular risk stratification of patients with psoriatic diseaseJune 5, 2019Psoriatic Arthritis
Active psoriatic arthritis, ankylosing spondylitis linked to increase in adverse pregnancy outcomesMay 20, 2019Ankylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
